Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT | Zendy

Chris Harding | Zendy; Thomas Chadwick | Zendy; Tara Homer | Zendy; Jan Lecouturier | Zendy; Helen Mossop | Zendy; Sonya Carnell | Zendy; William King | Zendy; Alaa Abouhajar | Zendy; Luke Vale | Zendy; Gillian Watson | Zendy; Rebecca Forbes | Zendy; Stephanie Currer | Zendy; Robert Pickard | Zendy; Ian Eardley | Zendy; Ian Pearce | Zendy; Nikesh Thiruchelvam | Zendy; Karen Guerrero | Zendy; Katherine Walton | Zendy; Zahid Hussain | Zendy; Henry Lazarowicz | Zendy; Ased Ali | Zendy

Open Access

Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT

Author(s) -

Chris Harding,

Thomas Chadwick,

Tara Homer,

Jan Lecouturier,

Helen Mossop,

Sonya Carnell,

William King,

Alaa Abouhajar,

Luke Vale,

Gillian Watson,

Rebecca Forbes,

Stephanie Currer,

Robert Pickard,

Ian Eardley,

Ian Pearce,

Nikesh Thiruchelvam,

Karen Guerrero,

Katherine Walton,

Zahid Hussain,

Henry Lazarowicz,

Ased Ali

Publication year - 2022

Publication title -

health technology assessment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.426

H-Index - 126

eISSN - 2046-4924

pISSN - 1366-5278

DOI - 10.3310/qoiz6538

Subject(s) - medicine , urinary system , nitrofurantoin , bacteriuria , randomized controlled trial , antibiotics , antibiotic prophylaxis , antibiotic resistance , surgery , microbiology and biotechnology , biology

Daily, low-dose antibiotic prophylaxis is the current standard care for women with recurrent urinary tract infection. Emerging antimicrobial resistance is a global health concern, prompting research interest in non-antibiotic agents such as methenamine hippurate, but comparative data on their efficacy and safety are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research